In addition, we showed that in the group of patients with type 1 diabetes with anti-EBNA-1 antibodies in the IgG class, the percentage of CD3+CD4+IL-10+ T cells was significantly higher (p = 0.033; Figure 6C). The gene discussed is IL10; the disease is type 1 diabetes mellitus.